Intrinsic Imaging
Ophthalmologist in front of OCT retinal scans and fundus photography monitors

Ophthalmology Imaging Core Lab Division

Intrinsic Imaging provides imaging core lab services in support of ophthalmology clinical trials. Our subspecialty ophthalmologists provide centralized independent review of examinations acquired to equipment-specific standards, supporting the evaluation of safety and efficacy in retinal, macular, optic nerve and other ophthalmic indications. Intrinsic Imaging extends these services beyond imaging to visual-function assessments, so sponsors can coordinate structural and functional endpoints within a single study.

At Intrinsic Imaging, our Ophthalmology Imaging division brings together more than 35 board-certified, fellowship-trained ophthalmologists who have participated in more than 160 ophthalmology clinical trials as principal investigators or reviewers. Their expertise spans a broad spectrum of ophthalmic indications, including diabetic retinopathy, age-related macular degeneration, retinitis pigmentosa and other inherited retinal diseases, epiretinal membrane, macular hole, retinal tears, and retinal detachment.

Intrinsic Imaging supports ophthalmic endpoints across an extensive range of structural, functional, angiographic, and electrophysiologic assessments, including optical coherence tomography (OCT), color fundus photography (CFP), fundus autofluorescence (FAF), near-infrared autofluorescence, fluorescein angiography, adaptive optics retinal imaging, best-corrected visual acuity (BCVA), visual field assessments, electroretinography (ERG), full-field stimulus testing (FST), intraocular pressure (IOP), and functional MRI. Our teams work closely with sponsors from protocol development and imaging charter design through regulatory-ready data delivery to define imaging and assessment strategies suited to the indication and the protocol, qualify sites and equipment, standardize acquisition, maintain image quality control, train and qualify readers, and conduct centralized independent review with adjudication and quantitative analysis.

By combining ophthalmic subspecialty expertise with consistent acquisition and review methods, Intrinsic Imaging helps sponsors reduce variability across imaging systems, operators, readers, and follow-up visits. Anatomical or functional change can then be distinguished from differences in how an examination was performed or interpreted, supporting reliable longitudinal assessments in ophthalmology programs from early-phase investigation through pivotal trials.

Ophthalmology Imaging Division Highlights

  • Intrinsic Imaging provides specialized imaging and independent assessment services for ophthalmology clinical trials.
  • 35+ board-certified and fellowship-trained ophthalmologists.
  • Our ophthalmologists have participated in 160+ ophthalmology clinical trials as principal investigators or reviewers.
  • Intrinsic Imaging combines structural imaging expertise with visual-function, angiographic and electrophysiologic assessments.
  • Modality expertise includes:
    • Optical Coherence Tomography (OCT)
    • Color Fundus Photography (CFP)
    • Adaptive Optics (AO) retinal imaging
    • Best Corrected Visual Acuity (BCVA)
    • Electroretinography (ERG)
    • Fluorescein Angiography
    • Full Field Stimulus Testing (FST)
    • Functional MRI
    • Fundus Autofluorescence (FAF)
    • Intra Ocular Pressure (IOP)
    • Near infrared Autofluorescence (AF) imaging
    • Visual Field Assessments

Ophthalmic Reading Center Services

Intrinsic Imaging’s ophthalmic reading center provides centralized independent review of the assessments defined in the study protocol. Our ophthalmologists evaluate structural, functional, angiographic, and electrophysiologic findings using study-specific review methods, bringing specialist interpretation to trials in retinal and other ophthalmic diseases.

OCT, Fundus Imaging and Visual Function Endpoints

Intrinsic Imaging coordinates the imaging and visual-function assessments required by each trial. OCT and fundus imaging characterize retinal structure, while angiography, autofluorescence, and adaptive optics imaging address complementary findings. BCVA, visual fields, ERG, full-field stimulus testing, and other functional assessments remain distinct measures, interpreted according to their role in the protocol.

Site and Equipment Qualification

Intrinsic Imaging combines site and equipment qualification with acquisition instructions, centralized image quality control, and reader training. These controls address differences between imaging systems, sites, and follow-up visits that could otherwise obscure longitudinal change or introduce inconsistency into endpoint assessments.

Retinal Imaging, Grading and Visual Function Assessments

Intrinsic Imaging applies equipment-specific acquisition instructions and centralized quality control to retinal imaging and visual-function assessments. Our teams coordinate these activities within the study while preserving the distinction between image-derived outcomes and functional testing. The methods below illustrate how our assessments address different indications and endpoints.

Indication or endpointMethodsMeasures
Neovascular AMD and DMEOCT, fluorescein angiographySubfield thickness, retinal fluid, lesions, leakage
Geographic atrophyAutofluorescence, color photography, OCTAtrophy area, lesion growth, outer-retinal change
Diabetic retinopathyStandardized color fundus photographyETDRS severity grading and longitudinal change
Inherited retinal diseaseOCT, autofluorescence, electrophysiologyRetinal structure, ellipsoid zone, functional response
GlaucomaOCT, optic-disc imaging, perimetryNerve fiber layer, ganglion cells, visual-field change
Visual functionBCVA, visual fields, ERG, FSTSeparate indication-specific functional assessments

OCT Segmentation and Retinal Fluid Review

Intrinsic Imaging checks OCT signal, scan centering, coverage, and segmentation before quantitative assessment. Our readers review automated boundaries and apply documented correction rules before measurements are released. Consistent assessment of fluid compartments, retinal thickness, and anatomical change supports comparison across visits, with equipment and software changes recorded as part of the study history.

Fundus Grading and Angiographic Endpoints

Intrinsic Imaging defines fundus photography requirements for field coverage, illumination, and image quality, then applies the study’s selected disease-severity scale and comparison rules. Our fluorescein angiography review addresses phase timing, leakage, and lesion characterization. Autofluorescence assessments measure atrophy area with traceable lesion boundaries, supporting review of how measurements were derived.

Site, Photographer and Equipment Qualification

Intrinsic Imaging qualifies imaging equipment and acquisition personnel using study instructions and representative submissions. Sites receive feedback on focus, centering, field coverage, and incomplete examinations, while repeat training and ongoing quality monitoring address acquisition inconsistencies across equipment and follow-up visits.

Image grading and functional testing have separate training requirements and data checks. Intrinsic Imaging delivers their results with evaluability flags and documented query resolution, allowing sponsors to integrate structural and functional findings while preserving the meaning of each assessment.

Featured Case Study

Intrinsic Imaging

Ophthalmology

Geographic Atrophy and Neovascular AMD Trial

  • SD-OCT, fundus autofluorescence
  • Lesion area measurement
  • Multi-reader consensus

Challenge

The trial's efficacy assessments depended on precise central measurement of geographic atrophy lesion area and consistent longitudinal tracking of choroidal neovascularization. Lesion boundaries in retinal imaging are frequently indistinct, and small differences in how those boundaries are delineated translate into meaningful differences in measured area—differences large enough to confound endpoint analysis when measurements are compared across timepoints and readers.

Read the case study
View all case studies

More Ophthalmology case studies

Frequently Asked Questions

Why can studies in the same therapeutic area need different Intrinsic Imaging readers?
Intrinsic Imaging selects readers for their experience with the specific indication and assessment method. A solid-tumor study using RECIST 1.1, a glioma study using RANO and a lymphoma study using Lugano therefore require different combinations of clinical and interpretive expertise, even though all three fall within oncology.
Is Intrinsic Imaging the only imaging core lab with five BSI ISO certifications?
Yes. Intrinsic Imaging is the only imaging core lab in the world to hold five BSI ISO certifications specifically for providing imaging core lab services for clinical trials: ISO 9001, ISO 13485, ISO 22301, ISO/IEC 27001 and ISO/IEC 27018.
Who is the sponsor’s primary contact at Intrinsic Imaging?
A designated project manager is the sponsor’s primary contact at Intrinsic Imaging for timelines, deliverables, and operational questions. The sponsor’s medical monitor also speaks directly with Intrinsic Imaging’s board-certified physicians about clinical and assessment questions.
Go to more Frequently Asked Questions

Tell us about your trial.

Planning an Ophthalmology trial? Our team will respond within one business day.